Cyclovirobuxine D raw medicine and method for determining its content in preparation by chromatography

The invention relates to a technology of cyclovir buxus and raw materials, which is applied to the detection of an evaporative light scattering detector. , In the field of high performance liquid chromatography, it can solve the problems of cumbersome operation, easy storage failure, poor specificity, etc., and achieve the effect of simple operation method, strong versatility and simple method.

Inactive Publication Date: 2006-06-14
TIANJIN TASLY PHARMA CO LTD
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The main component of Buxus Ning, Cyclovitamin D, and other components are all alkaloids, so the non-aqueous titration method recorded on page 153 of the 2000 edition of the Chinese Pharmacopoeia is a classic method for determining alkaloids. This method is simple, but the specificity is poor. That is, as long as it is an alkaloid, it can be detected, so the result obtained is the total alkaloid content of the alkaloid, that is, the total amount of cyclovirboxicin D and other components, and cyclovirboxicin D is only one of the alkaloids. This detection method cannot accurately determine the true content of Cyclovitamin D
[0005] The preparation Huangyangning tablets produced with Huangyangning as the original drug, the method contained in page 575 of its "Chinese Pharmacopoeia" 2000 edition is the acid dye colorimetric method, which is cumbersome to operate and has poor specificity. can be detected, so the result obtained is the total alkaloid content of alkaloids, that is, the total amount of cyclovirboxicin D and its related substances, and cyclovirboxicin D is only one of the alkaloids, and this detection method can also Unable to accurately determine the true content of Cycloviral Buxicine D
[0006] The preparations Huangyangning dripping pills and Huangyangning powder injections produced with Buyangning as the original drug are currently also using acid dye colorimetry to measure the content of cyclovirbuxuxin D contained in them, that is, the measured is also the total alkaloid content of alkaloids, which cannot Accurate Determination of the Content of Cyclovitamin D in it
[0007] Because of the disadvantages of poor specificity in the above-mentioned determination methods, many researchers are actively looking for highly specific determination methods, especially high-performance liquid chromatography, such as pre-column derivatization high-performance liquid chromatography, end-absorption high-performance liquid chromatography, high-efficiency Liquid phase-mass spectrometry, etc., but these methods all have such and such shortcomings
[0008] Using pre-column derivatization high-performance liquid chromatography to determine the content of cyclovirboxicin D, it is necessary to make cyclovirboxicin D generate a new compound through a chemical reaction before sample injection, and then convert the content of the new compound into a ring The content of vitamin Buxicine D, so it is an indirect determination method. Ester is a harmful liquid and is used as a lachrymator. It is irritating, photosensitive, and sensitive to light and humidity. It must be stored after being filled with nitrogen. Conventional storage is prone to failure. Long-term use will cause great harm to the human body, so it is not recommended Suitable for use as a derivatization reagent to determine the content of Cyclovirubuxin D
[0009] Application No.: 200310106142.8, Publication No.: CN 1540339A The invention patent uses terminal absorption high performance liquid chromatography to determine the content of cyclovirbuxuxin D, but this method uses aminopropylsilane bonded silica gel as a filler, and its versatility is not strong; Moreover, the terminal absorption 210nm is used for detection, and the selectivity is not strong. Therefore, the pretreatment operation is cumbersome when measuring the cyclovirbuxuxin D in Huangyangning tablets, Huangyangning dripping pills and Huangyangning powder injections.
[0010] In addition, there are also literatures using high-performance liquid chromatography-mass spectrometry. This method has poor precision and is expensive. At present, people basically do not use this method as a method for the determination of Cyclovitamin D.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cyclovirobuxine D raw medicine and method for determining its content in preparation by chromatography
  • Cyclovirobuxine D raw medicine and method for determining its content in preparation by chromatography
  • Cyclovirobuxine D raw medicine and method for determining its content in preparation by chromatography

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Huanwei Buxus D raw material medicine is commercially available (produced by Henan Longdu Pharmaceutical Factory)

[0046] Chromatographic conditions and system adaptability The stationary phase uses octadecylsilane bonded silica gel as a filler; ammonium formate buffer solution (take 15.0 g of ammonium formate, add 10 ml of formic acid, add water to dissolve and dilute to 1000 ml)-methanol (volume ratio of 62:38) is the mobile phase; the flow rate is 0.8ml / min; evaporative light scattering detector: the drift tube temperature is 100°C, and the gas flow rate is 2.7L / min; the column temperature is 30°C; in the chromatogram of the test solution, The D peak of Cyclovitamin and other alkaloid peaks should be separated by baseline; the number of theoretical plates should be no less than 2000 based on the calculation of Cyclovitamin D peak.

[0047] Preparation of Reference Substance Solution Use phosphorus pentoxide as a desiccant, and dry at 60°C under reduced pressure to c...

Embodiment 2

[0056] Embodiment two (cyclovir buxicine D reference substance purity inspection)

[0057] Cyclovitamin D reference substance (purchased from China Institute for Pharmaceutical and Biological Products Inspection, batch number 888-200001)

[0058] Chromatographic conditions and system adaptability The stationary phase uses octadecylsilane bonded silica gel as a filler; ammonium formate buffer solution (take 15.0 g of ammonium formate, add 10 ml of formic acid, add water to dissolve and dilute to 1000 ml)-methanol (volume ratio of 62:38) is the mobile phase; the flow rate is 0.8ml / min; evaporative light scattering detector: the drift tube temperature is 100°C, and the gas flow rate is 2.7L / min; the column temperature is 30°C; in the chromatogram of the test solution, The D peak of Cyclovitamin and other alkaloid peaks should be separated by baseline; the number of theoretical plates should be no less than 2000 based on the calculation of Cyclovitamin D peak.

[0059] Preparatio...

Embodiment 3

[0063] Embodiment three (purity inspection of the raw material of refined cyclovir buxicine D)

[0064] Refined Huowei Buxus D raw material (provided by Henan Kangli Pharmaceutical Technology Development Co., Ltd.)

[0065] Chromatographic conditions and system adaptability The stationary phase uses octadecylsilane bonded silica gel as a filler; ammonium formate buffer solution (take 15.0 g of ammonium formate, add 10 ml of formic acid, add water to dissolve and dilute to 1000 ml)-methanol (volume ratio of 63:37) is mobile phase; Flow rate is 0.8ml / min; Evaporative light scattering detector: drift tube temperature is 100 ℃, and gas flow rate is 2.7L / min; Column temperature is 30 ℃; In the chromatogram of need testing solution, The D peak of Cyclovitamin and other alkaloid peaks should be separated by baseline; the number of theoretical plates should be no less than 2000 based on the calculation of Cyclovitamin D peak.

[0066] Preparation of the test solution Take 10 mg of re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Cyclovirobuxine-D raw material drug and high efficiency liquid chromatography mensuration for Cyclovirobuxine-D content in different kinds of preparation, and high efficiency liquid chromatography for impurity testing in Cyclovirobuxine-D. The fixed phase in chromatographic condition uses octadecyl silane linkage silica gel or octyl silane linkage silica gel as filling material; The mobile phase adopt formate (ammonium formate) damping fluid-methanol system, acetic acid (ammonium acetate) damping fluid-methanol system, formate (ammonium formate) damping fluid-acetonitrile system or acetic acid (ammonium acetate) damping fluid-acetonitrile system; Evaporation light scattering detector (ELSD) detects drift tube temperature; drift tube temperature: 20-150 degree centigrade;and gas flow rate: 0.1L / min- 6.0L / min, split-flow or not split stream sampling. The method is easy to operate, timesaving, and has strong expert attribute. It could effectively divide some kind of alkaloids that has with Cyclovirobuxine-D in Cyclovirobuxine-D raw material drug. Thus, it is able to accurately measure their content. The method could also detecting impurity in Cyclovirobuxine-D. The invention could also measure content degree of homogeneity of Cyclovirobuxine-D in boxwood-nin piece, boxwood-nin drop pill, and boxwood-nin powder pin. And it commendably satisfies the request of pharmacopoeia content and content degree of homogeneity testing.

Description

technical field [0001] The present invention relates to a high-performance liquid chromatography method for determining the content of cyclovitamin D in the bulk drug and various preparations thereof (such as Huangyangning tablets, Huangyangning dripping pills, Huangyangning powder injections, etc.) and cyclovitamin D. High performance liquid chromatography for impurity check in D. In particular it involves the use of high performance liquid chromatography with detection using an evaporative light scattering detector (ELSD). Background technique [0002] The alkaloids extracted and refined from Buxus mincrophylla Sieb.et Zucc.var.sinica Rehd.et Wils. and the whole plant of the Buxus family plant, if the content of the main component Cyclovitamin D is greater than 70%, That is, Huowei Buxusing D raw material drug, also known as Huangyang Ning. [0003] At present, the commonly used assay methods for the raw material of cyclovir buxicine D or ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/88G01N30/02G01N30/06G01N30/60G01N30/74
Inventor 李伟魏峰
Owner TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products